Electrocardiographic Abnormalities in Trypanosoma cruzi Seropositive and Seronegative Former Blood Donors

Carregando...
Imagem de Miniatura
Citações na Scopus
50
Tipo de produção
article
Data de publicação
2013
Título da Revista
ISSN da Revista
Título do Volume
Editora
PUBLIC LIBRARY SCIENCE
Autores
RIBEIRO, Antonio L.
MARCOLINO, Milena S.
ANTUNES, Andre
MENEZES, Marcia
OLIVEIRA, Claudia Di Lorenzo
Citação
PLOS NEGLECTED TROPICAL DISEASES, v.7, n.2, article ID e2078, 8p, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Blood donor screening leads to large numbers of new diagnoses of Trypanosoma cruzi infection, with most donors in the asymptomatic chronic indeterminate form. Information on electrocardiogram (ECG) findings in infected blood donors is lacking and may help in counseling and recognizing those with more severe disease. Objectives: To assess the frequency of ECG abnormalities in T. cruzi seropositive relative to seronegative blood donors, and to recognize ECG abnormalities associated with left ventricular dysfunction. Methods: The study retrospectively enrolled 499 seropositive blood donors in Sao Paulo and Montes Claros, Brazil, and 483 seronegative control donors matched by site, gender, age, and year of blood donation. All subjects underwent a health clinical evaluation, ECG, and echocardiogram (Echo). ECG and Echo were reviewed blindly by centralized reading centers. Left ventricular (LV) dysfunction was defined as LV ejection fraction (EF), 0.50%. Results: Right bundle branch block and left anterior fascicular block, isolated or in association, were more frequently found in seropositive cases (p<0.0001). Both QRS and QTc duration were associated with LVEF values (correlation coefficients -0.159, p<0.0003, and -0.142, p = 0.002) and showed a moderate accuracy in the detection of reduced LVEF (area under the ROC curve: 0.778 and 0.790, both p<0.0001). Several ECG abnormalities were more commonly found in seropositive donors with depressed LVEF, including rhythm disorders (frequent supraventricular ectopic beats, atrial fibrillation or flutter and pacemaker), intraventricular blocks (right bundle branch block and left anterior fascicular block) and ischemic abnormalities (possible old myocardial infarction and major and minor ST abnormalities). ECG was sensitive (92%) for recognition of seropositive donors with depressed LVEF and had a high negative predictive value (99%) for ruling out LV dysfunction. Conclusions: ECG abnormalities are more frequent in seropositive than in seronegative blood donors. Several ECG abnormalities may help the recognition of seropositive cases with reduced LVEF who warrant careful follow-up and treatment.
Palavras-chave
Referências
  1. ARTEAGA-FERNANDEZ E, 1985, Arquivos Brasileiros de Cardiologia, V44, P333
  2. Bern C, 2009, CLIN INFECT DIS, V49, pE52, DOI 10.1086/605091
  3. Biolo A, 2010, PROG CARDIOVASC DIS, V52, P300, DOI 10.1016/j.pcad.2009.11.008
  4. CASADO J, 1990, INT J CARDIOL, V27, P55, DOI 10.1016/0167-5273(90)90191-7
  5. de Bruyne MC, 1999, AM J EPIDEMIOL, V150, P1282
  6. Dekker JM, 1997, AM J EPIDEMIOL, V145, P899
  7. Denes P, 2007, JAMA-J AM MED ASSOC, V297, P978, DOI 10.1001/jama.297.9.978
  8. DIAS J C P, 1968, Revista do Instituto de Medicina Tropical de Sao Paulo, V10, P158
  9. Dias JCP, 2007, MEM I OSWALDO CRUZ, V102, P11, DOI 10.1590/S0074-02762007005000092
  10. ESPINOSA RA, 1991, INT J CARDIOL, V30, P195, DOI 10.1016/0167-5273(91)90095-7
  11. Garzon S A, 1995, Sao Paulo Med J, V113, P802
  12. GASCON J, 2009, ACTA TROP, V115, P22, DOI 10.1016/J.ACTATROPICA.2009.07.019
  13. Goncalves JGF, 2011, REV SOC BRAS MED TRO, V44, P40, DOI 10.1590/S0037-86822011000800007
  14. Guerrero L, 1991, Arq Bras Cardiol, V56, P465
  15. Hamilton RM, 2004, INT J CARDIOL, V95, P109, DOI 10.1016/j.ijcard.2003.07.002
  16. JUNQUEIRA LF, 1990, BRAZ J MED BIOL RES, V23, P1091
  17. Junqueira LF, 2012, REV SOC BRAS MED TRO, V45, P243, DOI 10.1590/S0037-86822012000200020
  18. Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005
  19. Lima-Costa MF, 2010, INT J CARDIOL, V145, P362, DOI 10.1016/j.ijcard.2010.02.036
  20. Macfarlane PW, 2007, J ELECTROCARDIOL, V40, P101, DOI 10.1016/j.jelectrocard.2006.05.003
  21. Williams-Blangero S, 2007, AM J TROP MED HYG, V77, P495
  22. MAGUIRE JH, 1987, CIRCULATION, V75, P1140
  23. MAGUIRE JH, 1983, AM HEART J, V105, P287, DOI 10.1016/0002-8703(83)90529-X
  24. Nascimento BR, 2012, J ELECTROCARDIOL, V45, P43, DOI [10.1016/j.jelectrocard.2011.04.011, 10.1016/j.jelectrocard.2011.04.01]
  25. PORTO CELMO CELENO, 1964, ARQ BRASIL CARDIOL, V17, P313
  26. Prineas RJ, 1982, MINNESOTA CODE MANUA
  27. Rautaharju PM, 2004, AM J CARDIOL, V93, P1017, DOI 10.1016/j.amjcard.2003.12.055
  28. Ribeiro AL, 2012, NAT REV CARDIOL, V9, P576, DOI 10.1038/nrcardio.2012.109
  29. Ribeiro ALP, 2001, AM HEART J, V141, P260, DOI 10.1067/mhj.2001.111406
  30. Ribeiro ALP, 2005, INT J CARDIOL, V103, P225, DOI 10.1016/j.ijcard.2004.11.007
  31. Ribeiro ALP, 2008, J CARDIOVASC ELECTR, V19, pE41, DOI 10.1111/j.1540-8167.2008.01173.x
  32. Ribeiro ALP, 2006, INT J CARDIOL, V109, P34, DOI 10.1016/j.ijcard.2005.05.048
  33. Ribeiro ALP, 2000, PACE, V23, P2014
  34. Rincon LG, 2006, REV SOC BRAS MED TRO, V39, P245, DOI 10.1590/S0037-86822006000300003
  35. Rocha MOC, 2009, MEM I OSWALDO CRUZ, V104, P159, DOI 10.1590/S0074-02762009000900022
  36. Rodriguez-Salas LA, 1998, ECHOCARDIOGR-J CARD, V15, P271, DOI 10.1111/j.1540-8175.1998.tb00607.x
  37. Sabino EC, 2013, TRANSFUSION, V53, P1257, DOI 10.1111/j.1537-2995.2012.03902.x
  38. Sabino EC, 2013, CIRCULATION IN PRESS
  39. Sabino EC, 2010, TRANSFUSION, V50, P2628, DOI 10.1111/j.1537-2995.2010.02756.x
  40. Salles G, 2003, CIRCULATION, V108, P305, DOI 10.1161/01.CIR.00000749174.13444.9C
  41. Salles GF, 2004, AM J CARDIOL, V93, P1136, DOI 10.1016/j.amjcard.2004.01.040
  42. Salles GF, 2003, PACE, V26, P1326, DOI 10.1046/j.1460-9592.2003.t01-1-00190.x
  43. Salles NA, 1996, TRANSFUSION, V36, P969, DOI 10.1046/j.1537-2995.1996.36111297091740.x
  44. Salvatella R, 2007, MEM I OSWALDO CRUZ, V102, P39, DOI 10.1590/S0074-02762007005000105
  45. Valerio L, 2011, EURO SURVEILL, V16
  46. Villar JC, 2004, INT J CARDIOL, V93, P189, DOI 10.1016/j.ijcard.2003.03.002
  47. World Health Organization, 2010, WHOHTMNTDIDM20101
  48. World Health Organization, 2010, 1 M LEPT BURD EP REF, P1
  49. Zaniello BA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001771